Thank you for the question.
We are currently reviewing our regulatory guidelines on genetic modification and technologies related to genome editing. We held some broad consultations last year and are now doing some follow‑up work with stakeholders who have given us their comments.
As you may know, the points of view are rather divergent. Before publishing these new guidelines, we want to make sure that they are based on the best available scientific advice, that they are transparent to Canadians, that they are predictable for people in the industry and that they encourage innovation.